Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Buds & Duds: Cannabis stocks on upswing; CB2 Insights, KushCo report strong results

What are you searching for? Buds today are  Inc () (OTCMKTS:CBIIF), KushCo Holdings Inc (), Biome Grow Inc () (OTCMKTS:BIOIF).  Duds are Harborside In...

NA Proactive news snapshot: KinerjaPay, CB2 Insights, Orgenesis, Silvercorp Metals UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive () CEO E...

Buds & Duds: Cannabis stocks on upswing; CB2 Insights, KushCo report strong results

Cannabis analytics company CB2 Insights posted record third-quarter revenue of C$4.2 million, a 29% increase from the previous quarter Also making mov...

CB2 Insights posts record 3Q revenue of C$4.2M, boosted by strategic acquisitions

CEO Prad Sekar said it was a milestone quarter as it reflected the first full reporting period that included revenue from all three clinical businesse...

NA Proactive news snapshot: Alianza Minerals, CB2 Insights, EuroLife Brands, MGX Minerals, DXI Energy UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive () share...

Buds & Duds: Cannabis stocks stay flat but CB2 Insights flies on revenue-generating quarter

A 29% revenue increase during its third quarter helped propel the cannabis analytics firm higher on Friday Also moving was The Green Organic Dutchman,...

CB2 Insights reports unaudited 3Q revenue of C$4.2M, a 29% increase from previous quarter

The company also narrowed its adjusted-EBITDA loss by about 64% from the 2Q and saw its first-ever month of positive adjusted-EBITDA in August CB2 sai...

CB2 Insights announces new partnership with VIVO Cannabis for cannabis-based medical treatment

Its clinical data management software and electronic data capture tools will be integrated to create a better understanding of VIVO’s medical patient ...

CB2 Insights licenses electronic data capture software to UK firm MYACCESS Clinics

What are you searching for? viewCB2 Insights Inc. (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the ...

Buds & Duds: Cannabis stocks trend lower; CB2 Insights rises on new UK deal

CB2 will license its technology to the UK's MyAccess Clinics to manage their patient data. Cannabis stocks trended lower on Thursday across the US and...

CB2 Insights strengthens presence in UK medical cannabis market with MyAccess Clinics tie-up

MyAccess Clinics operates multiple clinics in the UK and is focused on providing care for patients with unmet needs The firm's Electronic Data Capture...

CB2 Insights enters Colombian medical cannabis market

It also appointed Dr Paola Cubillos, a prominent Colombian naturopathic and integrative medicine physician, as its medical director in the country Col...

CB2 Insights reports double-digit increase in 2Q revenue

For the quarter ended June 30, CB2 said its revenue was C$3.3 million, a 14.3% increase over the previous quarter The Toronto-based company gathers po...

Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from former J&J executive

What are you searching for? viewCB2 Insights Inc. Buds today are () (OTCQB:CBIIF), Cannvas MedTech Inc () (OTCMKTS:CANVF). Duds are Canopy Growth Corp...

CB2 Insights names former Johnson & Johnson executive to its board of directors

Peter Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles The appointment brings the size of CB2’s board...

Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from former Johnson & Johnson executive

Also on the move were Cannvas MedTech, Harvest Health & Recreation, Canopy Growth and Choom CB2 Insights rose as it named former J&J executive...

Buds & Duds: Cannabis stocks inch down on Monday, but CB2 Insights on the rise

CB2 Insights shares were on the rise Monday after announcing last week it is expanding its data analytics platform into the UK Cannabis stocks had a l...

Cb2 Insights signs letter of Intent with UK company, Drug Science for research program TWENTY21

What are you searching for? viewCB2 Insights Inc. (CSE: CBII-OTCQB: CBIIT) CEO Prad Sekar joined Steve Darling on Skype from London with news the comp...

CB2 Insights expands data analytics platform to the UK through new medical cannabis pilot program

Project TWENTY21 is a new project to assess the efficacy, safety, quality of life and health outcomes for 20,000 patients using cannabinoid therapies ...

CB2 Insights ready to move to Phase two of study with primary care physicians tool

What are you searching for? viewCB2 Insights Inc. (CSE: CBII) CEO Prad Sekar joined Steve Darling from Proactive Investors Vancouver to discuss the co...


MjInvest.com